Management of Mild GERD in Elderly Patients

Introduction to GERD Management

The American Gastroenterological Association recommends starting with H2-receptor antagonists (H2RAs) such as famotidine 20 mg twice daily, combined with lifestyle modifications, for elderly patients with mild GERD, as this approach provides effective symptom control with a more favorable safety profile than proton pump inhibitors for this population 1, 2, 3

Weight loss should be recommended for all overweight or obese elderly patients, as this has the strongest evidence for efficacy and can prevent the need for escalating pharmacotherapy 1, 2, 3, 4
Elevate the head of the bed by 6-8 inches for patients with nighttime symptoms or regurgitation, as this improves esophageal pH profiles 1, 2, 3, 4
Avoid lying down for 2-3 hours after meals to reduce esophageal acid exposure by 30-50% 1, 2, 3, 4
Individualize dietary restrictions based on specific symptom triggers (coffee, chocolate, alcohol, spicy foods, citrus) rather than broadly restricting all potential triggers 1, 3, 4

Proton pump inhibitors (omeprazole 20 mg once daily or lansoprazole 30 mg once daily) are superior to H2RAs but should be reserved for more severe disease or H2RA failures in elderly patients 1, 2, 3, 4
Take PPIs 30-60 minutes before breakfast for optimal acid suppression 3, 4

Alginates are recommended as first-line treatment for mild-to-moderate GERD in some regional consensus statements, particularly useful for neutralizing the post-prandial acid pocket 1
Alginates can be used as adjunctive therapy when symptoms are only partially responsive to H2RAs or PPIs 1
Alginates provide rapid, short-term relief for breakthrough symptoms and may be particularly useful in elderly patients with post-prandial or nighttime symptoms 3

If symptoms persist on standard PPI, increase to twice-daily PPI dosing 1, 2, 3, 4
After symptom control, titrate to lowest effective dose to minimize long-term medication exposure 1, 3, 4

Do not use metoclopramide as monotherapy or adjunctive therapy due to unfavorable risk-benefit profile, including risk of tardive dyskinesia, particularly concerning in elderly patients 1, 2
Do not broadly restrict all potential dietary triggers; instead, identify and avoid only those foods that consistently provoke symptoms in the individual patient 1, 3, 4
Do not add nocturnal H2RA to twice-daily PPI as standard practice, as there is no evidence of improved efficacy and tachyphylaxis develops with continued H2RA use 1